Literature DB >> 10962609

Long-term results of augmentation cystoplasty in spinal cord injury patients.

E J Chartier-Kastler1, P Mongiat-Artus, M O Bitker, M B Chancellor, F Richard, P Denys.   

Abstract

STUDY
DESIGN: Prospective monocentric follow-up study.
OBJECTIVES: To assess long-term functional and urodynamic results of augmentation enterocystoplasty in spinal cord injury (SCI) patients with detrusor hyperreflexia and reflex incontinence who failed to respond to conservative treatment. SETTINGS: Department of Urology (Pitié-Salpétrière Hospital, Paris, France), Department of Neurological Rehabilitation (Raymond Poincaré Hospital, Garches, France), Assistance Publique - Hopitaux de Paris, University Paris VI and V, France.
METHODS: Prospective study of 17 SCI patients (four above T6 level, nine between T6 and T12, and four below T12) with history of refractory urge incontinence to pharmacotherapy. Partial cystectomy (subtrigonal for 15) was performed with Hautmann enterocystoplasty (15) or detubularized clam cystoplasty (two).
RESULTS: Mean follow-up was 6.3+/-3.8 years (range 1.25 - 10.5 years). Fifteen of 17 (88.5%) patients were completely continent under self clean intermittent catheterization (CIC) (mean 4.6/day, range 4 - 7). The remaining two patients with pudendal nerve denervation had persistent stress urinary incontinence. No operative complications were noted. Long-term complications included recurrent pyelonephritis for one patient. Maximal cystometric capacity increased from 174.1+/-103.9 to 508.1+/-215.8 ml (P<0.05). Maximal end filling pressure decreased from 65.5+/-50.2 to 18.3+/-7.9 cm H2O (P<0.05).
CONCLUSION: Urodynamic evaluation and clinical assessment demonstrate long-term success of augmentation enterocystoplasty in an homogeneous population (SCI) without delayed complications in SCI patients.

Entities:  

Mesh:

Year:  2000        PMID: 10962609     DOI: 10.1038/sj.sc.3101033

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  13 in total

1.  Robot-assisted laparoscopic augmentation ileocystoplasty: a case report.

Authors:  Il-Sang Kang; Jaw-Whan Lee; Ill-Young Seo
Journal:  Int Neurourol J       Date:  2010-04-30       Impact factor: 2.835

2.  Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers.

Authors: 
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

Review 3.  Current trends in minimally invasive reconstructive urology.

Authors:  I Belibasakis; G Kolostoumpis; K Makrygiannaki
Journal:  J Robot Surg       Date:  2011-11-05

Review 4.  Neurogenic bladder: from diagnosis to management.

Authors:  Ellen Goldmark; Benjamin Niver; David A Ginsberg
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

5.  Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity.

Authors:  Priya Padmanabhan; Harriette M Scarpero; Douglas F Milam; Roger R Dmochowski; David F Penson
Journal:  World J Urol       Date:  2010-11-26       Impact factor: 4.226

6.  Long-term clinical and urodynamic effectiveness of augmentation ileocystoplasty with supra-trigonal cystectomy in individuals with spinal cord injury.

Authors:  A Balanca; A Even; C Malot; E Chartier-Kastler; P Denys; C Joussain
Journal:  World J Urol       Date:  2022-06-10       Impact factor: 3.661

7.  Managing the urinary tract in spinal cord injury.

Authors:  Simon C W Harrison
Journal:  Indian J Urol       Date:  2010-04

Review 8.  Repeated botulinum toxin injection for idiopathic overactive bladder: will chemodenervation become a long-term solution?

Authors:  Darius J Unwala; Paholo Barboglio; Angelo E Gousse
Journal:  Curr Urol Rep       Date:  2007-09       Impact factor: 3.092

9.  Cost-effectiveness analysis of onabotulinumtoxinA (BOTOX(®)) for the management of urinary incontinence in adults with neurogenic detrusor overactivity: a UK perspective.

Authors:  Rizwan Hamid; Clara Loveman; Jim Millen; Denise Globe; Catherine Corbell; Danielle Colayco; Sanja Stanisic; Dmitry Gultyaev
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

Review 10.  Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence.

Authors:  Jonathan D Campbell; Katharine S Gries; Jonathan H Watanabe; Arliene Ravelo; Roger R Dmochowski; Sean D Sullivan
Journal:  BMC Urol       Date:  2009-11-20       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.